Post by
Red~One on Apr 07, 2022 8:13pm
Historical or Hysterical Info
Regarding the latest NR in respect to the mention of the Barda Grant ..........................On May 19, 2020, Kalytera announced that it had signed a Letter of Intent dated May 12, 2020 (the “LOI”) to acquire Salzman Group. At that time, a valuable asset of Salzman Group was its contract with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services. Under this contract, BARDA awarded Salzman Group USD $15.9 million to develop R-107 as a treatment for chlorine inhalation lung injury (“CILI”). An additional USD $69.9 million could have been released to Salzman Group over the next 36 months, as developmental milestones were achieved. Under GAAP, these U.S. government funds would have been recognized as contract revenues when received over that period, and it was anticipated that Salzman Group would recognize net operating profits of approximately USD $1.4 million per year from these contract revenues. However, on September 16, 2020, Salzman Group was informed that BARDA was terminating the BARDA Contract and diverting its funding under the BARDA Contract, and all similar contracts, to support projects for prevention of COVID-19 infection. The Company was not informed directly of this from BARDA, but learned about this afterward from Salzman Group.
Comment by
Canary001 on Apr 08, 2022 9:26am
Can you tell me why you think that was a sham? I bought right after that PR.
Comment by
Canary001 on Apr 08, 2022 11:16am
The GVHD program was given to Talent Biotech, not Salzman. I do my homework befor I invest. If you hate the company, PLEASE sell as fast and as much as you can. I would love to average down. PLEASE SELL!
Comment by
Red~One on Apr 08, 2022 11:36am
The GHVD program and research was not "GIVEN" to Talent , it was a payment for money/security owed. That is CLAS' modus operandi....why use cash if you can defer it to shares?
Comment by
Canary001 on Apr 08, 2022 12:39pm
Talent owned the GVHD technology. Claritas acquired Talent in order to get the GVHD technology. When Claritas couldn't monetize the technology via an out-license to a strategic partner it decided to give back Talent to its original shareholders. This is all in the public docs from Claritas. DO YOUR HOMEWORK! And in the meantime please sell sell sell so I can get more shares on the cheap.